Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals pty ltd - calcium fluoride, quantity: 500 ng; silicon dioxide, quantity: 33 mg - tablet, uncoated - excipient ingredients: soy polysaccharide; microcrystalline cellulose; acacia; maize starch; lactose monohydrate; magnesium stearate - mineral supplement.

Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

life radiopharma berlin gmbh - sodium fluoride (18 f) 100 mbq/ml - 4000 mbq/ml - solution for injection - 0,1-4 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - tenofovir alafenamide fumarate, quantity: 11.2 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; hyprolose; lactose monohydrate; magnesium stearate; sodium lauryl sulfate; microcrystalline cellulose; silicon dioxide; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - genvoya is indicated as a single tablet regimen for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25 kg who are either treatment?na?ve; or virologically suppressed (hiv-1 rna <50 copies/ml) on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see 5.1 pharmacodynamic properties, clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of genvoya. genvoya is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; silicon dioxide; croscarmellose sodium; magnesium stearate; sodium lauryl sulfate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - stribild is indicated as a single tablet regimen for the treatment of hiv infection in treatment-na?ve adults. stribild is also indicated in certain virologically suppressed (hiv1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of stribild (tenofovir df, emtricitabine or elvitegravir). stribild is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

dentsply llc. professional division trading as "sultan healthcare" - fluoride ion (unii: q80vpu408o) (fluoride ion - unii:q80vpu408o) - fluoride ion 9 mg in 1 g - topex® fluoride gels are indicated for topical application to teeth to aid in the prevention of dental caries. the non-acidic nature of neutral ph (naf) is recommended for patients with ceramic or composite restorations. treatment frequency should not exceed 4 treatments per year. hypersensitivity to fluoride. do not use if patient has a known allergy to fluoride or any of the other ingredients in this product.

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

dent-mat holdings, llc. - potassium nitrate (unii: ru45x2jn0z) (nitrate ion - unii:t93e9y2844), sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. do not use in children under 6 years of age unless recommended by a dentist or physician. 8.1 pregnancy pregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate or well controlled clinical studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in chil

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

den-mat holdings, llc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. do not use in children under 6 years of age unless recommended by a dentist or physician. 1 pregnancypregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate or well controlled clinical studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in childho

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

den-mat holdings, llc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. do not use in children under 6 years of age unless recommended by a dentist or physician. 1 pregnancypregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate or well controlled clinical studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in childho

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

den-mat holdings, llc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. do not use in children under 6 years of age unless recommended by a dentist or physician. 8.1 pregnancypregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate or well controlled clinical studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in child

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

dentsply llc. professional division trading as "dentsply professional" - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 20 mg in 1 g - for topical application to aid in the protection against dental caries. the non-acidic fluoride is safe for patients with porcelain, composite restorations, and sealants. hypersensitivity to fluoride